Bio-Rad Laboratories

American life science research firm

BIO NYSE SEC CIK 12208 LEI 549300ZC1GPV35XYDK53
Follow Bio-Rad Laboratories Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $656.4M +0.5% vs same quarter last year
Net income $458.6M +234.1% vs same quarter last year
EPS, diluted $17.02 +234% vs same quarter last year
Operating cash flow $96.4M −20.3% vs same quarter last year
Revenue by quarter
$667.5M
$585.4M
$651.6M
$653M
$693.2M
$592.1M
$651M
$656.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$4B−$2B$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$2.6B$759.9M
FY24$2.6B−$1.8B
FY23$2.7B−$637.3M
FY22$2.8B−$3.6B
FY21$2.9B$4.3B
FY20$2.5B$3.8B
FY19$2.3B$1.8B
FY18$2.3B$365.6M
FY17$2.2B$122.2M
FY16$2.1B$26M
FY15$2B$109.2M
FY14$2.2B$88.8M
FY13$2.1B$77.8M
FY12$2.1B$165.5M
FY11$2.1B$179M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2551.9%1.8%29.4%
FY2453.7%10.5%−71.9%
FY2353.4%12.6%−23.9%
FY2255.9%17.2%−129.5%
FY2156.1%17.1%145.6%
FY2056.5%16.6%149.8%
FY1954.4%9.9%76.1%
FY1853.4%−4.5%16%
FY1755%5.5%5.7%
FY1655%2.7%1.3%
FY1555.5%8.3%5.4%
FY1454.2%6.9%4.1%
FY1355.3%7.9%3.6%
FY1255.8%12.8%8%
FY1156.9%14.7%8.6%
Free cash flowOperating cash flow minus capital expenditure
−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$374.6M
FY24$289.6M
FY23$218.2M
FY22$81.6M
FY21$535.7M
FY20$476.4M
FY19$359.4M
FY18$155.7M
FY17−$7.2M
FY16$74.6M
FY15$74.2M
FY14$152.3M
FY13$62.5M
FY12$123.6M
FY11$159.8M
Returned to shareholdersDividends paid and shares bought back
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$295.5M
FY24$203.6M
FY23$428.7M
FY22$215.7M
FY21$50M
FY20$100M
FY19$28M
FY18$48.9M
FY17$2.9M
FY16$0
FY15$0
FY14$0
FY13$0
FY12$101K
FY11$0
Net margin vs the sectorMedian of Technology companies filing with the SEC
  • Bio-Rad Laboratories
  • Technology median
−200%−100%0%100%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBio-Rad LaboratoriesTechnology median
FY2529.4%−2.3%
FY24−71.9%−5%
FY23−23.9%−6.7%
FY22−129.5%−4.4%
FY21145.6%−1.7%
FY20149.8%−3%
FY1976.1%0%
FY1816%0.8%
FY175.7%2%
FY161.3%2.3%
FY155.4%3.1%
FY144.1%2.9%
FY133.6%3.9%
FY128%3.9%
FY118.6%5.7%